Literature DB >> 16700550

Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2.

Haowei Song1, Shunzhong Bao, Sasanka Ramanadham, John Turk.   

Abstract

Group VIA phospholipase A(2) (iPLA(2)beta) is expressed in phagocytes, vascular cells, pancreatic islet beta-cells, neurons, and other cells and plays roles in transcriptional regulation, cell proliferation, apoptosis, secretion, and other events. A bromoenol lactone (BEL) suicide substrate used to study iPLA(2)beta functions inactivates iPLA(2)beta by alkylating Cys thiols. Because thiol redox reactions are important in signaling and some cells that express iPLA(2)beta produce biological oxidants, iPLA(2)beta might be subject to redox regulation. We report that biological concentrations of H(2)O(2), NO, and HOCl inactivate iPLA(2)beta, and this can be partially reversed by dithiothreitol (DTT). Oxidant-treated iPLA(2)beta modifications were studied by LC-MS/MS analyses of tryptic digests and included DTT-reversible events, e.g., formation of disulfide bonds and sulfenic acids, and others not so reversed, e.g., formation of sulfonic acids, Trp oxides, and Met sulfoxides. W(460) oxidation could cause irreversible inactivation because it is near the lipase consensus sequence ((463)GTSTG(467)), and site-directed mutagenesis of W(460) yields active mutant enzymes that exhibit no DTT-irreversible oxidative inactivation. Cys651-sulfenic acid formation could be one DTT-reversible inactivation event because Cys651 modification correlates closely with activity loss and its mutagenesis reduces sensitivity to inhibition. Intermolecular disulfide bond formation might also cause reversible inactivation because oxidant-treated iPLA(2)beta contains DTT-reducible oligomers, and oligomerization occurs with time- and temperature-dependent iPLA(2)beta inactivation that is attenuated by DTT or ATP. Subjecting insulinoma cells to oxidative stress induces iPLA(2)beta oligomerization, loss of activity, and subcellular redistribution and reduces the rate of release of arachidonate from phospholipids. These findings raise the possibility that redox reactions affect iPLA(2)beta functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16700550      PMCID: PMC2044503          DOI: 10.1021/bi060502a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  106 in total

1.  Characterization of N-terminal processing of group VIA phospholipase A2 and of potential cleavage sites of amyloid precursor protein constructs by automated identification of signature peptides in LC/MS/MS analyses of proteolytic digests.

Authors:  Haowei Song; Silva Hecimovic; Alison Goate; Fong-Fu Hsu; Shunzhong Bao; Ilan Vidavsky; Sasanka Ramanadham; John Turk
Journal:  J Am Soc Mass Spectrom       Date:  2004-12       Impact factor: 3.109

2.  Cellular responses to excess phospholipid.

Authors:  I Baburina; S Jackowski
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

3.  Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1.

Authors:  Z Ma; X Wang; W Nowatzke; S Ramanadham; J Turk
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  Molecular characterization of cytosolic phospholipase A2-beta.

Authors:  C Song; X J Chang; K M Bean; M S Proia; J L Knopf; R W Kriz
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

5.  Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2.

Authors:  R T Pickard; B A Strifler; R M Kramer; J D Sharp
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain.

Authors:  H C Yang; M Mosior; B Ni; E A Dennis
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

7.  Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid.

Authors:  J M Pullar; C C Winterbourn; M C Vissers
Journal:  Am J Physiol       Date:  1999-10

8.  Cell cycle dependence of group VIA calcium-independent phospholipase A2 activity.

Authors:  Alex D Manguikian; Suzanne E Barbour
Journal:  J Biol Chem       Date:  2004-09-22       Impact factor: 5.157

9.  Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.

Authors:  Christopher M Jenkins; David J Mancuso; Wei Yan; Harold F Sims; Beverly Gibson; Richard W Gross
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

10.  Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2.

Authors:  M A Gijón; D M Spencer; A L Kaiser; C C Leslie
Journal:  J Cell Biol       Date:  1999-06-14       Impact factor: 10.539

View more
  16 in total

Review 1.  Discovering mechanisms of signaling-mediated cysteine oxidation.

Authors:  Leslie B Poole; Kimberly J Nelson
Journal:  Curr Opin Chem Biol       Date:  2008-03-07       Impact factor: 8.822

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Effects of endoplasmic reticulum stress on group VIA phospholipase A2 in beta cells include tyrosine phosphorylation and increased association with calnexin.

Authors:  Haowei Song; Henry Rohrs; Min Tan; Mary Wohltmann; Jack H Ladenson; John Turk
Journal:  J Biol Chem       Date:  2010-08-23       Impact factor: 5.157

Review 4.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

5.  Myeloperoxidase-dependent inactivation of surfactant protein D in vitro and in vivo.

Authors:  Erika C Crouch; Tim O Hirche; Baohai Shao; Rachel Boxio; Julien Wartelle; Rym Benabid; Barbara McDonald; Jay Heinecke; Sadis Matalon; Azzaq Belaaouaj
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

Review 6.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

Review 7.  Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.

Authors:  Ari Cedars; Christopher M Jenkins; David J Mancuso; Richard W Gross
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

Review 8.  Phospholipases A2 and inflammatory responses in the central nervous system.

Authors:  Grace Y Sun; Phullara B Shelat; Michael B Jensen; Yan He; Albert Y Sun; Agnes Simonyi
Journal:  Neuromolecular Med       Date:  2009-10-24       Impact factor: 3.843

9.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.

Authors:  Karina M Soares; Nicole Blackmon; Tong Ying Shun; Sunita N Shinde; Harold K Takyi; Peter Wipf; John S Lazo; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

10.  Evidence of Highly Conserved β-Crystallin Disulfidome that Can be Mimicked by In Vitro Oxidation in Age-related Human Cataract and Glutathione Depleted Mouse Lens.

Authors:  Xingjun Fan; Sheng Zhou; Benlian Wang; Grant Hom; Minfei Guo; Binbin Li; Jing Yang; Dennis Vaysburg; Vincent M Monnier
Journal:  Mol Cell Proteomics       Date:  2015-10-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.